| 000 | 01432 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515071151.0 | ||
| 264 | 0 | _c20070710 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a1120-6721 | ||
| 024 | 7 |
_a10.1177/112067210701700315 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYalvac, I Sagdic | |
| 245 | 0 | 0 |
_aPenetration of betaxolol HCL ionic suspension 0.25% and betaxolol HCL solution 0.50% into the aqueous humor. _h[electronic resource] |
| 260 |
_bEuropean journal of ophthalmology _c |
||
| 300 |
_a368-71 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacokinetics |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAqueous Humor _xmetabolism |
| 650 | 0 | 4 |
_aBetaxolol _xpharmacokinetics |
| 650 | 0 | 4 | _aCataract Extraction |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOphthalmic Solutions _xpharmacokinetics |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSuspensions _xpharmacokinetics |
| 700 | 1 | _aBasci, N E | |
| 700 | 1 | _aDulger, B | |
| 700 | 1 | _aDuman, S | |
| 773 | 0 |
_tEuropean journal of ophthalmology _gvol. 17 _gno. 3 _gp. 368-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/112067210701700315 _zAvailable from publisher's website |
| 999 |
_c17074944 _d17074944 |
||